Table 5 Distribution of patients with rheumatoid arthritis (n = 592) and controls (n = 646) according to the compound NFκB1 insertion or deletion and FCRL3 −169SNP genotype.
| NFκB1 | del/del | ins/del | ins/ins |
|---|---|---|---|
| Patients (Madrid and Granada) | |||
| FCRL3 | |||
| AA | 24 (29) | 68 (24) | 68 (30) |
| AG | 45 (54) | 145 (52) | 123 (53) |
| GG | 14 (17) | 66 (24) | 39 (17) |
| Controls (Madrid and Granada) | |||
| FCRL3 | |||
| A | 30 (31) | 112 (38) | 67 (27) |
| AG | 46 (47) | 137 (46) | 127 (51) |
| GG | 22 (22) | 48 (16) | 57 (23) |
del, deletions; FCRL3, Fc receptor‐like 3; ins, insertions; NFκB1, nuclear factor κB1; RA, rheumatoid arthritis; SNP, single‐nucleotide polymorphism.
Percentages are calculated across columns.
Overall FCRL3 genotype comparisons for each NFκB1 genotype, p = 0.54, p = 0.001 and p = 0.28, for del/del, ins/del and ins/ins patients, respectively.